QUS Technology for Identifying At-Risk Women for Spontaneous Preterm Birth
用于识别有自然早产风险的女性的 QUS 技术
基本信息
- 批准号:9212373
- 负责人:
- 金额:$ 60.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-11 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:37 weeks gestationAdultBasic ScienceBirthCervicalCervix UteriClinicalControl GroupsDataDevelopmentDiagnosisDisabled PersonsEarly DiagnosisEarly identificationEconomic BurdenEconomicsEffectivenessEligibility DeterminationEtiologyFailureFetusGoalsHealthcare SystemsHigh Risk WomanIncidenceIndividualInfantInterventionLengthLifeMeasurableMeasurementMeasuresMedicalMethodsModelingPerinatal mortality demographicsPilot ProjectsPredictive ValuePregnancyPremature BirthPremature LaborProgesteroneProgestinsProspective StudiesRecruitment ActivityReproducibilityResearchRiskRisk EstimateSignal TransductionSigns and SymptomsSocietiesSurvivorsSyndromeSystemTechniquesTechnologyTestingTimeTranslationsUltrasonographyWomanWomen&aposs Groupattenuationclinical carecostdesignexperiencehigh riskimprovedinnovationmultidisciplinarynovelperinatal morbiditypredictive modelingpreventprospectivequantitative ultrasoundscreeningtooltreatment responders
项目摘要
This proposed research will refine and prospectively validate the effectiveness of quantitative
ultrasound (QUS) technology [QUS parameters: cervical ultrasound attenuation coefficient (ATTEN),
cervical ultrasound backscatter coefficient (BSC)], when compared to ultrasound (US)-estimated
cervical length (CL), to identify women at risk for spontaneous preterm birth (sPTB). Preterm birth (PTB)
is defined as birth before 37 completed weeks' gestation (wks GA). Annually in the U.S., more than 440,000
infants are born preterm, and over 80,000 are born very preterm (prior to 32 wks). Consequences of PTB for
survivors are severe, can be life-long and cost society $30 billion annually, a cost that far exceeds that of any
major adult diagnosis. Predicting women at risk for sPTB has been medically challenging due to: 1) lack of
signs and symptoms of preterm labor until intervention is too late, and 2) lack of sufficiently sensitive screening
tools to signal sPTB risk early enough when an intervention would likely be effective. Spontaneous preterm
labor is a syndrome associated with multiple etiologies of which only a portion may be associated with cervical
insufficiency; however, regardless of the etiology of PTB, the cervix must remodel for passage of the fetus.
Novel QUS technology has been developed by our multidisciplinary investigative team and shows
promise for becoming a widely available and useful method for early detection of sPTB. QUS technology is a
feature that can readily be added to current clinical ultrasound systems, thereby reducing the time from basic
science innovation translation to improve clinical care of women. Our pilot studies show that women who
experienced sPTB have a significantly lower ATTEN at 20 wks GA (relative to full-term women at 20 wks), and
ATTEN at 20 wks more accurately predicts sPTB than CL at 24 wks. When both ATTEN and CL measures are
combined, sPTB prediction is improved.
Our goals are to identify: 1) women at risk for sPTB earlier and with better accuracy than with CL alone,
and 2) differences between women who do/do not respond to progestogen therapy. To achieve these goals,
we propose to quantify ATTEN, BSC & CL at two time points (20±2 & 24±2 wks GA; each exam separated by
4 wks) to identify individuals at greatest risk of sPTB. Our pilot data identified 20±2 wks to be sensitive to
ATTEN differences and 24±2 wks to be sensitive to CL differences. Three groups of women will be recruited:
1) prior sPTB, 2) short CL at 20 wks, and 3) low-risk control group.
Central hypothesis: Cervical ATTEN & BSC (alone or combined) at 20±2 wks are better than CL at 24±2
wks for detecting risk of sPTB; further, ATTEN, BSC & CL at 20±2 & 24±2 wks, when combined, are even
better for detecting risk of sPTB.
这项拟议的研究将完善并前瞻性地定量的有效性
超声(QUS)技术[QUS参数:宫颈超声注意系数(ATTEN),
与超声(美国)相比,宫颈超声反向散射系数(BSC)
宫颈长度(CL),以确定有自发早产(SPTB)风险的女性。
定义为在37个完成的几周妊娠(WKS GA)之前定义为出生。
婴儿是早产的,超过80,000人出生于撬ply pry的早产(32周之前)。
幸存者很严重,可能是终身的,每年花费300亿美元,这一成本远远超过任何
主要的成人诊断。
早产的迹象和症状,直到干预为时已晚,而2)缺乏足够敏感的筛查
足够早的SPTB危险的工具可能是自发的
劳动与多种病因有关,其中一部分可能
但是,不管PTB的病因如何,子宫颈都必须重塑胎儿。
新颖的QUS技术是由我们的多学科调查团队开发的,并显示
验证一种广泛可用且有用的方法用于早期检测SPTB。
可以准备到当前清洁超声系统的功能,从而减少了基本的时间
科学创新翻译以改善我们的妇女临床护理。
经过经验的SPTB在20周GA时的ATTEN明显较低(相对于20 wks的完整女性)和
在24 wks中,ATTEN在20周时更准确地预测了SPTB。
合并的SPTB预测得到了改善。
我们的目标是确定:1)与克隆人相比,妇女面临SPTB的风险,并且具有更好的准确性,
2)/不反应孕激素治疗以实现这些目标的女性之间的差异,
我们建议在两个时间点(20±2&24±2 wks ga;每次考试分开)量化Atten,BSC&CL
4周)确定我们的PILOT数据最大的风险。
将招募差异和24±2 wks对妇女的敏感敏感:
1)先前的SPTB,2)在20 wks时短Cl,3)低风险对照组。
中央假设:在20±2 WKS处的宫颈Atten&BSC(单独或合并)在24±2时要好于Cl
wks以进一步检测SPTB的风险;
更好地检测SPTB的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARBARA L MCFARLIN其他文献
BARBARA L MCFARLIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARBARA L MCFARLIN', 18)}}的其他基金
QUS Technology for Identifying At-Risk Women for Spontaneous Preterm Birth
用于识别有自然早产风险的女性的 QUS 技术
- 批准号:
10199613 - 财政年份:2020
- 资助金额:
$ 60.79万 - 项目类别:
QUS Technology for Identifying At-Risk Women for Spontaneous Preterm Birth
用于识别有自然早产风险的女性的 QUS 技术
- 批准号:
10164830 - 财政年份:2017
- 资助金额:
$ 60.79万 - 项目类别:
Biochemical, Biomechanical & Morphological Properties of Quantitative Ultrasound
生物化学、生物力学
- 批准号:
7934692 - 财政年份:2009
- 资助金额:
$ 60.79万 - 项目类别:
Biochemical, Biomechanical & Morphological Properties of Quantitative Ultrasound
生物化学、生物力学
- 批准号:
7738734 - 财政年份:2009
- 资助金额:
$ 60.79万 - 项目类别:
B Mode Ultrasound Microstructure of the Preterm Cervix
早产子宫颈的 B 型超声显微结构
- 批准号:
6650113 - 财政年份:2003
- 资助金额:
$ 60.79万 - 项目类别:
B Mode Ultrasound Microstructure of the Preterm Cervix
早产子宫颈的 B 型超声显微结构
- 批准号:
6807002 - 财政年份:2003
- 资助金额:
$ 60.79万 - 项目类别:
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
QUS Technology for Identifying At-Risk Women for Spontaneous Preterm Birth
用于识别有自然早产风险的女性的 QUS 技术
- 批准号:
10199613 - 财政年份:2020
- 资助金额:
$ 60.79万 - 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
- 批准号:
10087196 - 财政年份:2019
- 资助金额:
$ 60.79万 - 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
- 批准号:
10705607 - 财政年份:2019
- 资助金额:
$ 60.79万 - 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
- 批准号:
10162643 - 财政年份:2019
- 资助金额:
$ 60.79万 - 项目类别:
1/2 A randomized controlled trial of pravastatin to prevent preeclampsia in high-risk women
1/2 普伐他汀预防高危女性先兆子痫的随机对照试验
- 批准号:
10455106 - 财政年份:2019
- 资助金额:
$ 60.79万 - 项目类别: